FundedIQ
Advanced Materials

Myris Therapeutics: Funding, Investors & Team (Oct 2026)

Myris Therapeutics develops antibody drug conjugate therapies using polymer chemistry and ultra-high drug-to-antibody ratio technology.

www.myristx.com Sharpsburg, United States
Total raised
$500k
Rounds
1
Latest
Convertible Note
Oct 2026

Myris Therapeutics has raised $500k across 1 funding round on record, the most recent a Convertible Note of $500k announced in Oct 2026.

That round is below the $7.7M median round size for United States companies tracked on FundedIQ over the last two years.

Myris Therapeutics Company Profile and Key Stats

Total funding raised
$500k
across 1 round on record
Funding rounds on record
1
Latest funding round
Convertible Note
$500k in Oct 2026
Headquarters
Sharpsburg, United States

Latest funding round on record: Oct 2026.

Myris Therapeutics Funding Rounds

Date
Round
Amount
Convertible Note
$500k

Myris Therapeutics Founders and Leadership Team

Name
Role
Contact
Laura Benjamin
CEO and President, Myris Therapeutics
Locked
Antonina Simakova
Chief Technology Officer
Locked

Contact details for the Myris Therapeutics team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.

Start 14-day free trial →

Myris Therapeutics Funding in Context

Segment
Companies
Median round
30,319
$7.7M

Myris Therapeutics' latest round of $500k is below the median round in United States. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Myris Therapeutics in Advanced Materials and Sharpsburg

Companies Similar to Myris Therapeutics

TechNovaTime is a an IT Internet offering AI based automate platform for healthcare teams administrative…

Pre-Seed $3.4M

Metabolize provdies wellness and fitness services that helps with global metabolic health and obesity epidemic

Seed $3.2M

Shamrock AI is an enterprise AI platform focused on agentic assurance for SAP and complex enterprise…

Seed $5.0M

ExploreTech AI builds AI-powered tools that combine machine learning and geoscience data to help discover…

Undisclosed round $8.3M

Abby Care helps caregivers get Medicaid compensation for caring for children with disabilities or special…

Series C $82.0M

Secure the next endpoint: Enterprise AI (M365 Copilot, ChatGPT, Claude, Gemini). Trusted by UiPath, Wellstar,…

Seed $21.0M

Medcotec designs innovative powder transfer valves to make pharmaceutical manufacturing safer, cleaner, and…

Seed $3.2M

Fission is an institutional liquidity layer connecting asset holders, lending markets, and platforms for…

Series A $10.0M

Guardify is a digital platform that makes evidence management.

Undisclosed round $800k

Punch is a software platform that provides purchasing and accounts payable tools for construction…

Seed $2.0M

OpsMate AI transforms plant data, documents, and expert knowledge into industrial AI platform that powers…

Seed $3.4M

EMode Photonix develops simulation software for designing nonlinear integrated photonic and quantum photonic…

Pre-Seed $1.0M

Myris Therapeutics Funding FAQs

What does Myris Therapeutics do?

Myris Therapeutics develops antibody drug conjugate therapies using polymer chemistry and ultra-high drug-to-antibody ratio technology.

How much funding has Myris Therapeutics raised?

Myris Therapeutics has raised $500k across 1 round on record. The most recent is a Convertible Note of $500k announced in Oct 2026.

When did Myris Therapeutics last raise funding?

Myris Therapeutics' most recent funding round on record is a Convertible Note of $500k, announced in Oct 2026.

Who is the CEO of Myris Therapeutics?

Laura Benjamin is listed as CEO and President, Myris Therapeutics at Myris Therapeutics.

Where is Myris Therapeutics headquartered?

Myris Therapeutics is based in Sharpsburg, United States.

About FundedIQ's Myris Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Myris Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.